Rosacea Treatment Market Size, Share & Trends Report

Rosacea Treatment Market Size, Share & Trends Analysis Report By Drug Class (Alpha Agonists, Antibiotics, Retinoids, Corticosteroids), By Mode of Administration (Topical, Oral), By Region, And Segment Forecasts, 2019 - 2025

  • Published Date: Jan, 2019
  • Base Year for Estimate: 2017
  • Report ID: GVR-2-68038-739-1
  • Format: Electronic (PDF)
  • Historical Data: 2014 - 2016
  • Number of Pages: 83

Table of Contents

Chapter 1 Methodology and Scope
                   1.1 Research Methodology
                   1.2 Research Scope and Assumptions
                   1.3 List of Tables
Chapter 2 Executive Summary
                   2.1 Market Summary
Chapter 3 Market Variables, Trends & Scope
                   3.1 Market Segmentation
Chapter 4 Market Definitions
                   4.1 Disease Primer and Epidemiology
                   4.2 Market Segmentation
Chapter 5 Industry Outlook
                   5.1 Market Driver Analysis
                       5.1.1 Surging geriatric population
                       5.1.2 Advanced formulations of drugs
                       5.1.3 Shift towards combination therapies
                       5.1.4 Increase in disease prevalence
                   5.2 Market Restraint Analysis
                       5.2.1 Generic penetration
                       5.2.2 Off-label usage of drugs
Chapter 6 Business Environment Analysis
                   6.1 SWOT Analysis; By factor (political & legal, economic and technological)
                   6.2 Porter’s Five Forces Analysis
                   6.3 Pipeline Analysis
Chapter 7 Drug Class Business Analysis
                   7.1 Rosacea Treatment market: Drug Class Movement Analysis
                   7.2 Antibiotics
                       7.2.1 Antibiotics market estimates and forecast, 2014 - 2025
                   7.3 Alpha Agonists
                       7.3.1 Alpha agonists market estimates and forecast, 2014 - 2025
                   7.4 Retinoids
                       7.4.1 Retinoids market estimates and forecast, 2014 - 2025
                   7.5 Corticosteroids
                       7.5.1 Corticosteroids market estimates and forecast, 2014 - 2025
                   7.6 Immunosuppressants
                       7.6.1 Immunosuppressants market estimates and forecast, 2014 - 2025
                   7.7 Antihypertensive Agents
                       7.7.1 Antihypertensive agents market estimates and forecast, 2014 - 2025
                   7.8 Others
                       7.8.1 Others market estimates and forecast, 2014 - 2025
Chapter 8 Mode Of Administration Business Analysis
                   8.1 Rosacea Treatment market: Mode of Administration Movement Analysis
                   8.2 Topical
                       8.2.1 Topical market estimates and forecast, 2014 - 2025
                   8.3 Oral
                       8.3.1 Oral market estimates and forecast, 2014 - 2025
Chapter 9 Regional Business Analysis
                   9.1 Rosacea Treatment Market: Regional Movement Analysis
                   9.2 North America
                       9.2.1 North America market estimates and forecast, 2014 - 2025
                       9.2.2 U.S.
                           9.2.2.1 U.S. market estimates and forecast, 2014 - 2025
                       9.2.3 Canada
                           9.2.3.1 Canada market estimates and forecast, 2014 - 2025
                   9.3 Europe
                       9.3.1 Europe market estimates and forecast, 2014 - 2025
                       9.3.2 Germany
                       9.3.3 Germany market estimates and forecast, 2014 - 2025
                       9.3.4 U.K.
                       9.3.5 U.K. market estimates and forecast, 2014 - 2025
                   9.4 Asia-Pacific
                       9.4.1 Asia-Pacific market estimates and forecast, 2014 - 2025
                       9.4.2 Japan
                           9.4.2.1 Japan market estimates and forecast, 2014 - 2025
                       9.4.3 China
                           9.4.3.1 China market estimates and forecast, 2014 - 2025
                       9.4.4 India
                           9.4.4.1 India market estimates and forecast, 2014 - 2025
                   9.5 Latin America
                       9.5.1 Latin America market estimates and forecast, 2014 - 2025
                       9.5.2 Brazil
                           9.5.2.1 Brazil market estimates and forecast, 2014 - 2025
                       9.5.3 Mexico
                           9.5.3.1 Market estimates and forecast, 2014 - 2025
                   9.6 Middle East and Africa
                       9.6.1 Middle-East and Africa market estimates and forecast, 2014 - 2025
                       9.6.2 South Africa
                       9.6.3 South Africa market estimates and forecast, 2014 - 2025
Chapter 10 Company Profile
                   10.1 Company Profiles
                       10.1.1 Nestlé S.A.
                           10.1.1.1 Company Overview
                           10.1.1.2 Financial Performance
                           10.1.1.3 Product Benchmarking
                           10.1.1.4 Strategic Initiatives
                       10.1.2 Allergan Plc
                           10.1.2.1 Company Overview
                           10.1.2.2 Financial Performance
                           10.1.2.3 Product Benchmarking
                           10.1.2.4 Strategic Initiatives
                       10.1.3 Bayer Schering AG
                           10.1.3.1 Company Overview
                           10.1.3.2 Financial Performance
                           10.1.3.3 Product Benchmarking
                           10.1.3.4 Strategic Initiatives
                       10.1.4 Bausch Health Companies Inc.
                           10.1.4.1 Company Overview
                           10.1.4.2 Financial Performance
                           10.1.4.3 Product Benchmarking
                           10.1.4.4 Strategic Initiatives
                       10.1.5 Foamix Pharmaceuticals
                           10.1.5.1 Company Overview
                           10.1.5.2 Financial Performance
                           10.1.5.3 Product Benchmarking
                           10.1.5.4 Strategic Initiatives
                       10.1.6 Sol-Gel Technologies
                           10.1.6.1 Company Overview
                           10.1.6.2 Financial Performance
                           10.1.6.3 Product Benchmarking
                           10.1.6.4 Strategic Initiatives


List of Tables

Table 1 List of Abbreviation
Table 2 Rosacea Epidemiology - 2017
Table 3 Rosacea - Pipeline Intelligence
Table 4 North America Rosacea Market, by Drug Class, 2014 - 2025 (USD Million)
Table 5 North America Rosacea Market, by Mode of Administration, 2014 - 2025 (USD Million)
Table 6 U.S. Rosacea Market, by Drug Class, 2014 - 2025 (USD Million)
Table 7 U.S. Rosacea Market, by Mode of Administration, 2014 - 2025 (USD Million)
Table 8 Canada Rosacea Market, by Drug Class, 2014 - 2025 (USD Million)
Table 9 Canada Rosacea Market, by Mode of Administration, 2014 - 2025 (USD Million)
Table 10 Europe Rosacea Market, by Drug Class, 2014 - 2025 (USD Million)
Table 11 Europe Rosacea Market, by Mode of Administration, 2014 - 2025 (USD Million)
Table 12 U.K. Rosacea Market, by Drug Class, 2014 - 2025 (USD Million)
Table 13 U.K. Rosacea Market, by Mode of Administration, 2014 - 2025 (USD Million)
Table 14 Germany Rosacea Market, by Drug Class, 2014 - 2025 (USD Million)
Table 15 Germany Rosacea Market, by Mode of Administration, 2014 - 2025 (USD Million)
Table 16 Latin America Rosacea Market, by Drug Class, 2014 - 2025 (USD Million)
Table 17 Latin America Rosacea Market, by Mode of Administration, 2014 - 2025 (USD Million)
Table 18 Brazil Rosacea Market, by Drug Class, 2014 - 2025 (USD Million)
Table 19 Brazil Rosacea Market, by Mode of Administration, 2014 - 2025 (USD Million)
Table 20 Mexico Rosacea Market, by Drug Class, 2014 - 2025 (USD Million)
Table 21 Mexico Rosacea Market, by Mode of Administration, 2014 - 2025 (USD Million)
Table 22 Asia Pacific Rosacea Market, by Drug Class, 2014 - 2025 (USD Million)
Table 23 Asia Pacific Rosacea Market, by Mode of Administration, 2014 - 2025 (USD Million)
Table 24 Japan Rosacea Market, by Drug Class, 2014 - 2025 (USD Million)
Table 25 Japan Rosacea Market, by Mode of Administration, 2014 - 2025 (USD Million)
Table 26 China Rosacea Market, by Drug Class, 2014 - 2025 (USD Million)
Table 27 China Rosacea Market, by Mode of Administration, 2014 - 2025 (USD Million)
Table 28 India Rosacea Market, by Drug Class, 2014 - 2025 (USD Million)
Table 29 India Rosacea Market, by Mode of Administration, 2014 - 2025 (USD Million)
Table 30 MEA Rosacea Market, by Drug Class, 2014 - 2025 (USD Million)
Table 31 MEA Rosacea Market, by Mode of Administration, 2014 - 2025 (USD Million)
Table 32 South Rosacea Market, by Drug Class, 2014 - 2025 (USD Million)
Table 33 South Africa Rosacea Market, by Mode of Administration, 2014 - 2025 (USD Million)


List of Figures

Fig. 1 Rosacea treatment market snapshot
Fig. 2 Rosacea treatment drugs market segmentation
Fig. 3 Current disease prevalence - 2017
Fig. 4 Rosacea treatment market - driver impact
Fig. 5 Rosacea treatment market - restraint impact
Fig. 6 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 7 Porter’s five forces analysis
Fig. 8 Rosacea treatment market: Drug class outlook and key takeaways
Fig. 9 Rosacea treatment market: Drug class movement analysis
Fig. 10 Amtibiotics market estimates and forecast, 2014 - 2025 (USD Million)
Fig. 11 Antibiotics market estimates and forecast, 2014 - 2025 (USD Million)
Fig. 12 Alpha agonists market estimates and forecast, 2014 - 2025 (USD Million)
Fig. 13 Retinoids market estimates and forecast, 2014 - 2025 (USD Million)
Fig. 14 Corticosteroids market estimates and forecast, 2014 - 2025 (USD Million)
Fig. 15 Immunosuppressants market estimates and forecast, 2014 - 2025 (USD Million)
Fig. 16 Antihypertensive agents market estimates and forecast, 2014 - 2025 (USD Million)
Fig. 17 Others market estimates and forecast, 2014 - 2025 (USD Million)
Fig. 18 Rosacea treatment market: Mode of administration outlook and key takeaways
Fig. 19 Rosacea treatment market: Mode of administration movement analysis
Fig. 20 Topical market estimates and forecast, 2014 - 2025 (USD Million)
Fig. 21 Oral market estimates and forecast, 2014 - 2025 (USD Million)
Fig. 22 Rosacea Treatment Market: Regional Outlook and Key Takeaways
Fig. 23 Rosacea Treatment market: Regional movement analysis
Fig. 24 North America
Fig. 25 North America. market estimates and forecast, 2014 - 2025 (USD Million)
Fig. 26 U.S. market estimates and forecast, 2014 - 2025 (USD Million)
Fig. 27 Canada market estimates and forecast, 2014 - 2025 (USD Million)
Fig. 28 Europe
Fig. 29 Europe market estimates and forecast, 2014 - 2025 (USD Million)
Fig. 30 Germany market estimates and forecast, 2014 - 2025 (USD Million)
Fig. 31 U.K. market estimates and forecast, 2014 - 2025 (USD Million)
Fig. 32 Asia-Pacific
Fig. 33 Asia-Pacific market estimates and forecast, 2014 - 2025 (USD Million)
Fig. 34 Japan market estimates and forecast, 2014 - 2025 (USD Million)
Fig. 35 China market estimates and forecast, 2014 - 2025 (USD Million)
Fig. 36 India market estimates and forecast, 2014 - 2025 (USD Million)
Fig. 37 Latin America
Fig. 38 Latin America market estimates and forecast, 2014 - 2025 (USD Million)
Fig. 39 Brazil market estimates and forecast, 2014 - 2025 (USD Million)
Fig. 40 Mexico market estimates and forecast, 2014 - 2025 (USD Million)
Fig. 41 Middle East & Africa
Fig. 42 MEA market estimates and forecast, 2014 - 2025 (USD Million)
Fig. 43 South Africa market estimates and forecast, 2014 - 2025 (USD Million)
Fig. 44 Company profile

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.